Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...
Symptoms to look out for and when to see a doctor - There are roughly 10,000 people a year diagnosed with bladder cancer in ...
Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder ...
The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...
Researchers from the University of Sheffield and Barts Cancer Institute at Queen Mary, University of London have found that ...
A phase 3 clinical trial has shown that patients were 32 per cent less likely to experience cancer recurrence when treated ...
J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...
They were used on five patients, and four of them are now either in remission or cancer-free. Read more at straitstimes.com.
According to Bladder Cancer UK, the main symptoms of bladder cancer are: ...
A lung cancer drug already available on the NHS has been proven to cut bladder cancer deaths and reduce the risk of the ...